Inventor

POSY SHOSHANA L

US33 patents

Patents

33 patents

US10494370B2Dec 3, 2019

Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO15 citations94

US10487084B2Nov 26, 2019

Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO16 citations94

US10472361B2Nov 12, 2019

Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO16 citations94

US9688695B2Jun 27, 2017

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO11 citations90

US10457681B2Oct 29, 2019

Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO15 citations84

US10912766B2Feb 9, 2021

[1,2,4]triazolo[1,5-A]pyridinyl substituted indole compounds

BRISTOL MYERS SQUIBB CO6 citations83

US10822343B2Nov 3, 2020

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO4 citations83

US10428077B2Oct 1, 2019

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO8 citations83

US10047103B2Aug 14, 2018

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO11 citations83

US11306092B2Apr 19, 2022

Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO5 citations72

USRE49893EApr 2, 2024

[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds

BRISTOL MYERS SQUIBB CO1 citations71

US11420958B2Aug 23, 2022

Aryl and heteroaryl substituted indole compounds

BRISTOL MYERS SQUIBB CO3 citations71

US9862730B2Jan 9, 2018

Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO5 citations70

US12384760B2Aug 12, 2025

Substituted carbazole compounds

BRISTOL MYERS SQUIBB CO0 citations62

US11672780B2Jun 13, 2023

[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds

BRISTOL MYERS SQUIBB CO0 citations62

US10941145B2Mar 9, 2021

Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO0 citations62

US10927114B2Feb 23, 2021

Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO0 citations62

US10919895B2Feb 16, 2021

Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO0 citations62

US12162848B2Dec 10, 2024

Inhibitors of protein tyrosine phosphatase, compositions, and methods of use

BRISTOL MYERS SQUIBB CO1 citations61

US10981914B2Apr 20, 2021

Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO0 citations61

US12084452B2Sep 10, 2024

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO0 citations60

US12172995B2Dec 24, 2024

Substituted indole and indazole compounds

BRISTOL MYERS SQUIBB CO0 citations52

US10723736B2Jul 28, 2020

Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO0 citations52

US10711003B2Jul 14, 2020

Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO0 citations52

US10696676B2Jun 30, 2020

Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO0 citations52

US11739098B2Aug 29, 2023

Substituted indole compounds

BRISTOL MYERS SQUIBB CO0 citations51

US11485741B2Nov 1, 2022

Macrocyclic toll-like receptor 7 (TLR7) agonists

BRISTOL MYERS SQUIBB CO0 citations51

US12492188B2Dec 9, 2025

1H-benzo[D]imidazole derivatives as TLR9 inhibitors for the treatment of fibrosis

BRISTOL MYERS SQUIBB CO0 citations50

US11878975B2Jan 23, 2024

Substituted indole compounds useful as TLR inhibitors

BRISTOL MYERS SQUIBB CO0 citations50

POSY SHOSHANA L

Patents

Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor

Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor

Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor

[1,2,4]triazolo[1,5-A]pyridinyl substituted indole compounds

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

Amino indole compounds useful as TLR inhibitors

Benzothiazole and benzothiophene compounds

Amide substituted indole compounds useful as TLR inhibitors

Pyridyl substituted indole compounds

Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds

Aryl and heteroaryl substituted indole compounds

Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

Substituted carbazole compounds

[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds

Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor

Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor

Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor

Inhibitors of protein tyrosine phosphatase, compositions, and methods of use

Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

Substituted indole and indazole compounds

Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor

Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor

Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor

Substituted indole compounds

Macrocyclic toll-like receptor 7 (TLR7) agonists

1H-benzo[D]imidazole derivatives as TLR9 inhibitors for the treatment of fibrosis

Substituted indole compounds useful as TLR inhibitors